Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
Cross Country Healthcare, Inc.
CCRN
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $426.4M
$13.20
▲ 0.00%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$7.43 - $14.99
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 0.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Established brand recognition and 35+ year track record in healthcare staffing with deep client relationships
- Dual-segment model diversifying revenue across nurse/allied and physician staffing markets
- Comprehensive service offerings including MSP and RPO solutions that create sticky, long-term client contracts
- Large network of healthcare professionals and facilities providing scale advantages in matching supply and demand
Bear Case
2 risks
- Low volatility (beta 0.4).
- Extreme premium - high expectations embedded
Growth
Turning profitable
Emerging player in Medical - Care Facilities
Value
Extreme premium - high expectations embedded
Momentum
Hot
+43.8% over 3m
Quality
Thin
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying CCRN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 5, 2026
MAY 7, 2026
Reported EPS of -$0.03 vs -$0.05 consensus (+40.0% surprise). Revenue of $241.1M vs $237.1M expected (+1.7%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+40.0%
Next: May 5, 2026
Revenue trend · last 8Q
—
—
-25%
-23%
-19%
-21%
-24%
-18%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$339.8M
$315.1M
$309.9M
$293.4M
$274.1M
$250.1M
$236.8M
$241.1M
Margins · last 8Q
Gross
—
Operating
—
Profit
-1.8%
Wall Street consensus
3 analysts · 0% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
0%
Hold
100%
Sell
0%
Median Price Target
—
Latest: Truist · May 11, 2026